Clinical Trials Logo

Clinical Trial Summary

To determine the role of antibiotic prophylaxis in the surgical management of miscarriage.


Clinical Trial Description

Patients will be randomized to receive either prophylactic antibiotic [a single dose of oral doxycycline (200 mg) and metronidazole (500 mg)] or placebo using identical sealed envelopes.Included cases are those with early miscarriage (within the first trimester 12 6/7 weeks of gestation) , missed or incomplete miscarriage, undergoing surgical management will be included in the study. Technique: The investigators will prepare 138 identical envelops, half of them filled with a label group(1) who are the group to receive the antibiotic prophylaxis with all instruction details, while the other half filled with a label identifying ( group 2) who are the placebo group. All envelops will be prepared by the investigator and sealed before starting enrollment. After enrollment, each participant will be allowed to choose one envelop to determine to which group the patient will be assigned to. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05040334
Study type Interventional
Source Cairo University
Contact Marwa Mo Eid, Ass.professor
Phone 01001225079
Email marwameid2014@gmail.com
Status Recruiting
Phase Phase 4
Start date January 1, 2021
Completion date May 1, 2022

See also
  Status Clinical Trial Phase
Withdrawn NCT04230746 - Effect of Antibiotics on Urinary Microbiome Early Phase 1
Recruiting NCT04705259 - A Multimodal Intervention to Optimise Antimicrobial Use in Residential Aged Care Facilities (ENGAGEMENT Study) N/A
Not yet recruiting NCT04980170 - Clindamycin Versus Amoxicillin With Clavulanic Acid in Prevention of Early Dental Implants Failure Early Phase 1
Completed NCT03622008 - To Investigate the Multiple Dose Safety, Tolerability and Pharmacokinetics of WCK 4282 (FEP-TAZ) Phase 1
Enrolling by invitation NCT05020418 - De-Implementation of Inappropriate Antimicrobial Use After Cardiac Device Procedures N/A
Enrolling by invitation NCT05224687 - Utility Assessment of a Pharmacy-to-Dose Daptomycin